| Line Item | 2022-02-06 | Y/Y |
|---|---|---|
| Revenue | $2.18B | +29.5% |
| Cost of Revenue | $708.3M | +32.3% |
| Gross Profit | $1.47B | +28.2% |
| R&D Expense | $581.9M | +21.1% |
| SG&A Expense | $190.0M | +4.1% |
| Operating Income | -$98.4M | +62.3% |
| Interest Expense | $36.7M | +16.8% |
| Pre-tax Income | -$128.5M | +52.4% |
| Income Tax | $14.8M |
| Line Item | 2022-02-06 | Y/Y |
|---|---|---|
| Cash & Equivalents | $466.2M | +38.3% |
| Accounts Receivable | $542.1M | +17.6% |
| Inventory | $38.9M | -16.7% |
| Current Assets | $2.19B | +14.9% |
| Total Assets | $3.14B | +11.2% |
| Current Liabilities | $952.3M | +25.2% |
| Long-term Debt | $786.8M | +4.1% |
| Line Item | 2022-02-06 | Y/Y |
|---|---|---|
| Operating Cash Flow | $410.1M | +118.6% |
| Capital Expenditures | $102.3M | +7.7% |
| Investing Cash Flow | -$153.3M | +63.3% |
| Financing Cash Flow | -$127.8M | -163.8% |
| Free Cash Flow | $307.8M | +232.2% |
| +23.9% |
| Net Income | -$143.3M | +49.2% |
| EPS (Basic) | -$0.50 | +52.4% |
| EPS (Diluted) | -$0.50 | +52.4% |
| Total Liabilities |
| $2.38B |
| +15.1% |
| Stockholders' Equity | $754.3M | +0.6% |